Medline rises as investors weigh new customer wins and post-earnings reset

Medline Inc. (MDLN) is up 3.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a pair of fresh customer announcements this week that highlighted ongoing contract momentum, which may be helping sentiment recover after the sharp selloff that followed early-August earnings. This could also be a rebound trade, as investors revisit Medline’s still-strong sales growth and new-customer activity despite the company’s reduced full-year adjusted EBITDA outlook.

Details:

On August 28, Medline announced an expanded Prime Vendor agreement with Stillwater Medical Center that adds lab products to an existing relationship spanning more than 12 years.

On August 27, Medline said Ohio County Healthcare completed its transition to Medline as Prime Vendor, giving the health system access to medical-surgical products and distribution support across its network of facilities.

In second-quarter results released August 5, Medline posted 11.6% sales growth to $7.7 billion and said it had secured more than 65% of its annual goal for new customer signings in the first half of 2026.

The same earnings release also lowered full-year adjusted EBITDA guidance and disclosed a loss tied to the Tracy, California distribution-center fire, which had pressured the shares earlier this month and may now be setting up a relief bounce.

Sources:

Medline Newsroom, SEC, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MDLN Insider Trading Activity

$MDLN insiders have traded $MDLN stock on the open market 37 times in the past 6 months. Of those trades, 1 have been purchases and 36 have been sales.

Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:

8 HOLDINGS MOZART MANAGER L.L.C. BCP has made 0 purchases and 8 sales selling 61,170,810 shares for an estimated $2,345,618,751.
MOZART ML-2 HOLDCO L.P. BX has made 0 purchases and 8 sales selling 61,170,810 shares for an estimated $2,345,618,751.
& FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 8 sales selling 57,999,474 shares for an estimated $2,222,909,857.
GROUP CAYMAN INVESTMENT HOLDINGS, L.P. TC sold 26,105,840 shares for an estimated $1,070,339,440
GROUP INC. CARLYLE sold 26,105,840 shares for an estimated $1,070,339,440
MOZART COINVESTMENT HOLDINGS, L.P. CARLYLE sold 26,105,840 shares for an estimated $1,070,339,440
CIRCLE ML HOLDCO GP, LLC CP sold 26,105,840 shares for an estimated $1,070,339,440
PRIVATE LTD GIC has made 0 purchases and 6 sales selling 4,438,896 shares for an estimated $158,253,752.
DOUGLAS P GOLWAS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $3,677,115.
JESSI L CORCORAN (Principal Accounting Officer) purchased 5,000 shares for an estimated $170,750

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive MDLN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$MDLN Hedge Fund Activity

We have seen 320 institutional investors add shares of $MDLN stock to their portfolio, and 162 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CARLYLE GROUP INC. removed 28,219,323 shares (-13.1%) from their portfolio in Q2 2026, for an estimated $1,112,970,099
INVESCO LTD. added 17,383,322 shares (+82.9%) to their portfolio in Q2 2026, for an estimated $685,598,219
CAPITAL RESEARCH GLOBAL INVESTORS added 16,802,120 shares (+72.5%) to their portfolio in Q2 2026, for an estimated $662,675,612
H&F CORPORATE INVESTORS X, LTD. removed 15,599,171 shares (-18.0%) from their portfolio in Q2 2026, for an estimated $615,231,304
EGERTON CAPITAL (UK) LLP added 12,105,082 shares (+277.3%) to their portfolio in Q2 2026, for an estimated $477,424,434
FMR LLC added 10,407,002 shares (+28.5%) to their portfolio in Q2 2026, for an estimated $410,452,158
BLACKROCK, INC. added 9,469,927 shares (+56.0%) to their portfolio in Q2 2026, for an estimated $373,493,920

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MDLN Analyst Ratings

Wall Street analysts have issued reports on $MDLN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Tigress Financial issued a "Buy" rating on 05/13/2026

To track analyst ratings and price targets for $MDLN, check out Quiver Quantitative's $MDLN forecast page.

$MDLN Price Targets

Multiple analysts have issued price targets for $MDLN recently. We have seen 9 analysts offer price targets for $MDLN in the last 6 months, with a median target of $53.0.

Here are some recent targets:

Eric Coldwell from Baird set a target price of $45.0 on 06/03/2026
Glen Santangelo from Barclays set a target price of $45.0 on 06/01/2026
Navann Ty from BNP Paribas set a target price of $40.0 on 05/14/2026
Ivan Feinseth from Tigress Financial set a target price of $62.0 on 05/13/2026
David Larsen from BTIG set a target price of $55.0 on 05/07/2026
Lee Hambright from Bernstein set a target price of $54.0 on 05/07/2026
Patrick Donnelly from Citigroup set a target price of $55.0 on 05/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.